Evaluating the Efficacy of chemo in postmeno ER+ pts

[Hopeful]

Abstract:

http://www.abstracts2view.com/sabcs10/view.php?nu=SABCS10L_607

Poster:

http://www.abstracts2view.com/sabcs10/viewp.php?nu=P5-10-08

Hopeful

[Rich66]

[P5-10-08] Evaluating the Efficacy of Current Clinical Practice of Adjuvant Chemotherapy in Post-Menopausal Women with One to Three Positive Auxiliary Nodes and Estrogen and/or Progesterone Positive Early Stage Breast Cancer.


Conclusion: The treatment standard of adjuvant chemotherapy in addition to endocrine therapy for the majority of women with 1-3 LN+ and ER+/PR+ ESBC was not found to be associated with incremental survival benefit in comparison with previous standards. Our results suggest that a large number of patients with 1-3 LN+ and ER+/PR+ ESBC may not gain benefit from adding chemotherapy to endocrine therapy.